These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8550046)

  • 1. Allograft rejection in pediatric recipients of living related liver transplants.
    Alonso EM; Piper JB; Echols G; Thistlethwaite JR; Whitington PF
    Hepatology; 1996 Jan; 23(1):40-3. PubMed ID: 8550046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors.
    Toyoki Y; Renz JF; Mudge C; Ascher NL; Roberts JP; Rosenthal P
    Pediatr Transplant; 2002 Aug; 6(4):301-7. PubMed ID: 12234270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
    Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL
    Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation].
    Fan S; Zhang Z
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1092-4. PubMed ID: 11766604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study between living and cadaveric donors in pediatric liver transplantation.
    Oliveros FH; Santamaría ML; Gámez M; Murcia J; Leal N; Frauca E; Hierro L; Camarena C; de la Vega A; Bortolo G; Díaz MC; Jara P
    Transplant Proc; 2005 Nov; 37(9):3936-8. PubMed ID: 16386590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB; Hothersall E; Preston J; Brown AM; Hawley CM; Wall D; Griffin AD; Isbel NM; Nicol DL; Johnson DW
    Transplantation; 2003 Nov; 76(10):1452-7. PubMed ID: 14657685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with living related liver transplantation in 63 children.
    Otte JB; Reding R; de Ville de Goyet J; Sokal E; Lerut J; Janssen M; Rosati R; Hayez JY; Libert F; Paul K; Latinne D
    Acta Gastroenterol Belg; 1999; 62(3):355-62. PubMed ID: 10547903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of reduced-size liver transplants in children, including split livers and living related liver transplants.
    Brölsch CE; Stevens LH; Whitington PF
    Eur J Pediatr Surg; 1991 Jun; 1(3):166-71. PubMed ID: 1892803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the best immunosuppression in living donor liver transplantation?
    Ringe B; Moritz M; Zeldin G; Soriano H
    Transplant Proc; 2005 Jun; 37(5):2169-71. PubMed ID: 15964369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.